GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,422.00p
   
  • Change Today:
      9.00p
  • 52 Week High: 2,263.00
  • 52 Week Low: 1,296.00
  • Currency: UK Pounds
  • Shares Issued: 4,094.22m
  • Volume: 1,555,531
  • Market Cap: £58,220m
  • RiskGrade: 129

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
49.58% below the market average49.58% below the market average49.58% below the market average49.58% below the market average49.58% below the market average
46.67% below the sector average46.67% below the sector average46.67% below the sector average46.67% below the sector average46.67% below the sector average
1yr Revenue Growth
53.12% below the market average53.12% below the market average53.12% below the market average53.12% below the market average53.12% below the market average
40.54% below the sector average40.54% below the sector average40.54% below the sector average40.54% below the sector average40.54% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
55.53% above the market average55.53% above the market average55.53% above the market average55.53% above the market average55.53% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
26.47% below the market average26.47% below the market average26.47% below the market average26.47% below the market average26.47% below the market average
57.58% below the sector average57.58% below the sector average57.58% below the sector average57.58% below the sector average57.58% below the sector average
Price Book Ratio
53.97% below the market average53.97% below the market average53.97% below the market average53.97% below the market average53.97% below the market average
16.36% below the sector average16.36% below the sector average16.36% below the sector average16.36% below the sector average16.36% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
49.39% below the market average49.39% below the market average49.39% below the market average49.39% below the market average49.39% below the market average
14.75% below the sector average14.75% below the sector average14.75% below the sector average14.75% below the sector average14.75% below the sector average
Price Chg 3m
31.96% below the market average31.96% below the market average31.96% below the market average31.96% below the market average31.96% below the market average
21.31% above the sector average21.31% above the sector average21.31% above the sector average21.31% above the sector average21.31% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
42.42% below the market average42.42% below the market average42.42% below the market average42.42% below the market average42.42% below the market average
43.86% below the sector average43.86% below the sector average43.86% below the sector average43.86% below the sector average43.86% below the sector average
Momentum 20
90.18% below the market average90.18% below the market average90.18% below the market average90.18% below the market average90.18% below the market average
82.46% below the sector average82.46% below the sector average82.46% below the sector average82.46% below the sector average82.46% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
31.23% above the market average31.23% above the market average31.23% above the market average31.23% above the market average31.23% above the market average
78.95% above the sector average78.95% above the sector average78.95% above the sector average78.95% above the sector average78.95% above the sector average
ROCE
81.64% above the market average81.64% above the market average81.64% above the market average81.64% above the market average81.64% above the market average
86.67% above the sector average86.67% above the sector average86.67% above the sector average86.67% above the sector average86.67% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
88.43% above the market average88.43% above the market average88.43% above the market average88.43% above the market average88.43% above the market average
89.29% above the sector average89.29% above the sector average89.29% above the sector average89.29% above the sector average89.29% above the sector average
Forecast EPS
88.24% above the market average88.24% above the market average88.24% above the market average88.24% above the market average88.24% above the market average
77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
98.24% above the market average98.24% above the market average98.24% above the market average98.24% above the market average98.24% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Operating Profit Loss
98.71% above the market average98.71% above the market average98.71% above the market average98.71% above the market average98.71% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
97.06% above the market average97.06% above the market average97.06% above the market average97.06% above the market average97.06% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Cash
97.38% above the market average97.38% above the market average97.38% above the market average97.38% above the market average97.38% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
84.07% above the market average84.07% above the market average84.07% above the market average84.07% above the market average84.07% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Buys 1y
94.92% above the market average94.92% above the market average94.92% above the market average94.92% above the market average94.92% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
85.86% below the market average85.86% below the market average85.86% below the market average85.86% below the market average85.86% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Brokers Percent Neutral
68.32% above the market average68.32% above the market average68.32% above the market average68.32% above the market average68.32% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,422.00p
Change Today 9.00p
% Change 0.64 %
52 Week High 2,263.00
52 Week Low 1,296.00
Volume 1,555,531
Shares Issued 4,094.22m
Market Cap £58,220m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
83.48% above the market average83.48% above the market average83.48% above the market average83.48% above the market average83.48% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
52.76% below the market average52.76% below the market average52.76% below the market average52.76% below the market average52.76% below the market average
24.59% above the sector average24.59% above the sector average24.59% above the sector average24.59% above the sector average24.59% above the sector average
Income
66.67% above the market average66.67% above the market average66.67% above the market average66.67% above the market average66.67% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
78.44% below the market average78.44% below the market average78.44% below the market average78.44% below the market average78.44% below the market average
94.87% below the sector average94.87% below the sector average94.87% below the sector average94.87% below the sector average94.87% below the sector average

What The Brokers Say

Strong Buy 2
Buy 6
Neutral 15
Sell 1
Strong Sell 1
Total 25
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q3 Q2
Ex-Div 17-Nov-22 18-Aug-22
Paid 12-Jan-23 06-Oct-22
Amount 13.75p 16.25p

Trades for 31-Jan-2023

Time Volume / Share Price
13:59 94 @ 1,422.00p
13:59 94 @ 1,422.20p
13:59 152 @ 1,422.40p
13:59 104 @ 1,422.00p
13:59 87 @ 1,422.00p

GSK Key Personnel

CEO Emma Walmsley
CFO Iain Mackay

Top of Page